{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T11:47:50Z","timestamp":1782388070029,"version":"3.54.5"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncol Ther"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s40487-026-00444-9","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T14:52:49Z","timestamp":1779461569000},"page":"543-573","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Repurposing Syrosingopine for Cancer Therapy: Lactate Trapping and ISR Sensitization as Metabolic Vulnerabilities"],"prefix":"10.1007","volume":"14","author":[{"given":"Moslem","family":"Javidan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahdokht","family":"Abbasiniya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirous","family":"Jamalzehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsaneh","family":"Shafiei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Khodadadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"issue":"11","key":"444_CR1","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1016\/j.celrep.2018.11.043","volume":"25","author":"D Benjamin","year":"2018","unstructured":"Benjamin D, Robay D, Hindupur SK, et al. Dual inhibition of the lactate transporters MCT1 and MCT4 is synthetic lethal with metformin due to NAD+ depletion in cancer cells. Cell Rep. 2018;25(11):3047-58.e4.","journal-title":"Cell Rep"},{"key":"444_CR2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.molmet.2019.07.006","volume":"33","author":"VL Payen","year":"2020","unstructured":"Payen VL, Mina E, Van H\u00e9e VF, Porporato PE, Sonveaux P. Monocarboxylate transporters in cancer. Mol Metab. 2020;33:48\u201366.","journal-title":"Mol Metab"},{"key":"444_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/cells10051056","author":"C Schiliro","year":"2021","unstructured":"Schiliro C, Firestein BL. Mechanisms of metabolic reprogramming in cancer cells supporting enhanced growth and proliferation. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10051056.","journal-title":"Cells"},{"key":"444_CR4","volume":"42","author":"W Du","year":"2025","unstructured":"Du W, Zang B, Wo Y, Chen S. SLC16A3 (MCT4) expression in tumor immunity and metabolism: insights from pan-cancer analysis. Biochem Biophys Rep. 2025;42:102034.","journal-title":"Biochem Biophys Rep"},{"key":"444_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12060557","author":"C Buyse","year":"2022","unstructured":"Buyse C, Joudiou N, Warscotte A, et al. Evaluation of syrosingopine, an MCT inhibitor, as potential modulator of tumor metabolism and extracellular acidification. Metabolites. 2022. https:\/\/doi.org\/10.3390\/metabo12060557.","journal-title":"Metabolites"},{"issue":"12","key":"444_CR6","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1601756","volume":"2","author":"D Benjamin","year":"2016","unstructured":"Benjamin D, Colombi M, Hindupur SK, et al. Syrosingopine sensitizes cancer cells to killing by metformin. Sci Adv. 2016;2(12):e1601756.","journal-title":"Sci Adv"},{"issue":"4","key":"444_CR7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/path.6142","volume":"260","author":"D Benjamin","year":"2023","unstructured":"Benjamin D. An acid test for metformin. J Pathol. 2023;260(4):365\u20137.","journal-title":"J Pathol"},{"issue":"2","key":"444_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/path.6066","volume":"260","author":"A Van der Vreken","year":"2023","unstructured":"Van der Vreken A, Oudaert I, Ates G, et al. Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis. J Pathol. 2023;260(2):112\u201323.","journal-title":"J Pathol"},{"issue":"26","key":"444_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202300686","volume":"10","author":"S Wu","year":"2023","unstructured":"Wu S, Xu L, He C, et al. Lactate efflux inhibition by syrosingopine\/LOD co-loaded nanozyme for synergetic self-replenishing catalytic cancer therapy and immune microenvironment remodeling. Adv Sci Weinh. 2023;10(26):e2300686.","journal-title":"Adv Sci Weinh"},{"issue":"13","key":"444_CR10","doi-asserted-by":"publisher","first-page":"7205","DOI":"10.1021\/jacs.2c12772","volume":"145","author":"C Yang","year":"2023","unstructured":"Yang C, Wang M, Chang M, et al. Heterostructural nanoadjuvant CuSe\/CoSe(2) for potentiating ferroptosis and photoimmunotherapy through intratumoral blocked lactate efflux. J Am Chem Soc. 2023;145(13):7205\u201317.","journal-title":"J Am Chem Soc"},{"issue":"4","key":"444_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202204808","volume":"10","author":"J Zhao","year":"2023","unstructured":"Zhao J, Tian Z, Zhao S, et al. Insights into the effect of catalytic intratumoral lactate depletion on metabolic reprogramming and immune activation for antitumoral activity. Adv Sci Weinh. 2023;10(4):e2204808.","journal-title":"Adv Sci Weinh"},{"key":"444_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122883","volume":"314","author":"Z Yang","year":"2025","unstructured":"Yang Z, Zhou Y, Liu X, et al. Mitochondrial-uncoupling nanomedicine for self-heating and immunometabolism regulation in cancer cells. Biomaterials. 2025;314:122883.","journal-title":"Biomaterials"},{"key":"444_CR13","doi-asserted-by":"crossref","unstructured":"Br\u00e4utigam K, Straub J, Bihi AK, et al. Dual inhibition of lactate transporters MCT1 and MCT4 in pancreatic neuroendocrine tumors targets metabolic heterogeneity and functional redundancy. bioRxiv. 2025:2025.01.31.635625.","DOI":"10.1101\/2025.01.31.635625"},{"issue":"4","key":"444_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2023.101169","volume":"11","author":"M Guo","year":"2024","unstructured":"Guo M, Gou Y, Dong X, et al. Syrosingopine, an anti-hypertensive drug and lactate transporter (MCT1\/4) inhibitor, activates hepatic stellate cells and exacerbates liver fibrosis in a mouse model. Genes Dis. 2024;11(4):101169.","journal-title":"Genes Dis"},{"issue":"4","key":"444_CR15","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1161\/01.HYP.11.4.360","volume":"11","author":"F Lef\u00e8vre-Borg","year":"1988","unstructured":"Lef\u00e8vre-Borg F, Mathias O, Cavero I. Role of the sympathetic nervous system in blood pressure maintenance and in the antihypertensive effects of calcium antagonists in spontaneously hypertensive rats. Hypertension. 1988;11(4):360\u201370.","journal-title":"Hypertension"},{"issue":"4","key":"444_CR16","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/0091-3057(79)90123-0","volume":"11","author":"TJ Walsh","year":"1979","unstructured":"Walsh TJ, Palfai T. Peripheral catecholamines and memory: characteristics of syrosingopine-induced amnesia. Pharmacol Biochem Behav. 1979;11(4):449\u201352.","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"444_CR17","first-page":"5","volume":"23","author":"T Shibuya","year":"1985","unstructured":"Shibuya T, Sato K. Fluorescence histochemical studies of the effects of rauwolfia alkaloid derivatives on adrenergic vasomotor nerves. Int J Clin Pharmacol Ther. 1985;23(1):5\u201310.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"11","key":"444_CR18","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1002\/jps.2600681126","volume":"68","author":"LJ Loeffler","year":"1979","unstructured":"Loeffler LJ, Schran HF. Antibody specificity studies for reserpine, its metabolites, and synthetic reserpine congeners: radioimmunoassay. J Pharm Sci. 1979;68(11):1433\u20135.","journal-title":"J Pharm Sci"},{"issue":"6","key":"444_CR19","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/0091-3057(81)90053-8","volume":"15","author":"OM Brown","year":"1981","unstructured":"Brown OM, Palfai T, Wichlinski L. Effect of an amnesic dose of reserpine, syrosingopine or guanethidine on the levels of whole brain dopamine and norepinephrine in the mouse. Pharmacol Biochem Behav. 1981;15(6):911\u20134.","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"444_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1440-1681.1979.tb00001.x","volume":"6","author":"A Bilski","year":"1979","unstructured":"Bilski A, Robertson HH, Wale JL. A study of the relationship between cardiac beta-adrenoceptor blockade and intrinsic sympathomimetic activity in rats depleted of catecholamines. Clin Exp Pharmacol Physiol. 1979;6(1):1\u20139.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"444_CR21","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1476-5381.1970.tb10619.x","volume":"40","author":"AM Barrett","year":"1970","unstructured":"Barrett AM, Carter J. Comparative chronotropic activity of beta-adrenoceptive antagonists. Br J Pharmacol. 1970;40(3):373\u201381.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"444_CR22","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1476-5381.1959.tb00936.x","volume":"14","author":"JG Blackman","year":"1959","unstructured":"Blackman JG, Campion DS, Fastier FN. Mechanism of action of reserpine in producing gastric haemorrhage and erosion in the mouse. Br J Pharmacol Chemother. 1959;14(1):112\u20136.","journal-title":"Br J Pharmacol Chemother"},{"issue":"4","key":"444_CR23","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/0091-3057(79)90124-2","volume":"11","author":"TJ Walsh","year":"1979","unstructured":"Walsh TJ, Palfai T. Memory storage impairment or retrieval failure: pharmacologically distinguishable processes. Pharmacol Biochem Behav. 1979;11(4):453\u20136.","journal-title":"Pharmacol Biochem Behav"},{"issue":"6","key":"444_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06821-4","volume":"15","author":"Y Li","year":"2024","unstructured":"Li Y, Song Y, Shi Z, et al. Syrosingopine and UK5099 synergistically suppress non-small cell lung cancer by activating the integrated stress response. Cell Death Dis. 2024;15(6):431.","journal-title":"Cell Death Dis"},{"issue":"3","key":"444_CR25","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1021\/acs.jnatprod.3c00661","volume":"87","author":"Y Sadahiro","year":"2024","unstructured":"Sadahiro Y, Nishimura S, Hitora Y, Tsukamoto S. Syrosingopine enhances 20S proteasome activity and degradation of \u03b1-synuclein. J Nat Prod. 2024;87(3):554\u20139.","journal-title":"J Nat Prod"},{"key":"444_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.621458","volume":"10","author":"E Saulle","year":"2020","unstructured":"Saulle E, Spinello I, Quaranta MT, et al. Targeting lactate metabolism by inhibiting MCT1 or MCT4 impairs leukemic cell proliferation, induces two different related death-pathways and increases chemotherapeutic sensitivity of acute myeloid leukemia cells. Front Oncol. 2020;10:621458.","journal-title":"Front Oncol"},{"key":"444_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/bph.70110","author":"F Faghihkhorasani","year":"2025","unstructured":"Faghihkhorasani F, Moosavi M, Rasool Riyadh Abdulwahid AH, et al. Role of monocarboxylate transporters in cancer immunology and their therapeutic potential. Br J Pharmacol. 2025. https:\/\/doi.org\/10.1111\/bph.70110.","journal-title":"Br J Pharmacol"},{"issue":"4","key":"444_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/neup.70006","volume":"45","author":"MM Behera","year":"2025","unstructured":"Behera MM, Purkait S, Ghosh A, Sable MN, Sahu RN, Chhabra G. The monocarboxylate transporters MCT1 and MCT4 are highly expressed in glioblastoma and crucially implicated in the pathobiology. Neuropathology. 2025;45(4):e70006.","journal-title":"Neuropathology"},{"key":"444_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202414760","author":"L Chen","year":"2025","unstructured":"Chen L, Lin Y, Zhu X, et al. MCT1-mediated lactate shuttle to mitochondria governs macrophage polarization and modulates glucose homeostasis by affecting \u03b2 cells. Adv Sci. 2025. https:\/\/doi.org\/10.1002\/advs.202414760.","journal-title":"Adv Sci"},{"issue":"2","key":"444_CR30","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.cell.2020.11.043","volume":"184","author":"N Wang","year":"2021","unstructured":"Wang N, Jiang X, Zhang S, et al. Structural basis of human monocarboxylate transporter 1 inhibition by anti-cancer drug candidates. Cell. 2021;184(2):370-83.e13.","journal-title":"Cell"},{"issue":"6","key":"444_CR31","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1097\/XCS.0000000000000226","volume":"234","author":"B Zhao","year":"2022","unstructured":"Zhao B, Aggarwal A, Im SY, Viswanathan K, Landa I, Nehs MA. Effect of lactate export inhibition on anaplastic thyroid cancer growth and metabolism. J Am Coll Surg. 2022;234(6):1044\u201350.","journal-title":"J Am Coll Surg"},{"issue":"14","key":"444_CR32","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1039\/D2BM00650B","volume":"10","author":"LR Tian","year":"2022","unstructured":"Tian LR, Lin MZ, Zhong HH, et al. Nanodrug regulates lactic acid metabolism to reprogram the immunosuppressive tumor microenvironment for enhanced cancer immunotherapy. Biomater Sci. 2022;10(14):3892\u2013900.","journal-title":"Biomater Sci"},{"key":"444_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2023.147163","volume":"477","author":"J Wang","year":"2023","unstructured":"Wang J, Jiang W, Fang M, et al. Monocarboxylate transporter blockage-enabled lactate redistribution reshapes immunosuppressive tumor microenvironment and enhances chemodynamic immunotherapy. Chem Eng J. 2023;477:147163.","journal-title":"Chem Eng J"},{"key":"444_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.621458","volume":"10","author":"E Saulle","year":"2020","unstructured":"Saulle E, Spinello I, Quaranta M, et al. Targeting lactate metabolism by inhibiting MCT1 or MCT4 impairs leukemic cell proliferation, induces two different related death-pathways and increases chemotherapeutic sensitivity of acute myeloid leukemia cells. Front Oncol. 2020;10:621458. https:\/\/doi.org\/10.3389\/fonc.2020.621458.","journal-title":"Front Oncol"},{"issue":"8","key":"444_CR35","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1158\/1078-0432.CCR-22-2263","volume":"29","author":"S Halford","year":"2023","unstructured":"Halford S, Veal GJ, Wedge SR, et al. A phase\u00a0I dose-escalation study of AZD3965, an oral monocarboxylate transporter 1 inhibitor, in patients with advanced cancer. Clin Cancer Res. 2023;29(8):1429\u201339.","journal-title":"Clin Cancer Res"},{"key":"444_CR36","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.jconrel.2023.10.005","volume":"363","author":"Y Tong","year":"2023","unstructured":"Tong Y, Gu M, Luo X, et al. An engineered nanoplatform cascade to relieve extracellular acidity and enhance resistance-free chemotherapy. J Control Release. 2023;363:562\u201373.","journal-title":"J Control Release"},{"issue":"1","key":"444_CR37","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/s41467-025-56392-x","volume":"16","author":"C Niveau","year":"2025","unstructured":"Niveau C, Cettour-Cave M, Mouret S, et al. MCT1 lactate transporter blockade re-invigorates anti-tumor immunity through metabolic rewiring of dendritic cells in melanoma. Nat Commun. 2025;16(1):1083.","journal-title":"Nat Commun"},{"key":"444_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxrep.2025.101902","volume":"14","author":"AK Zaidi","year":"2025","unstructured":"Zaidi AK, Kumar A, Kumar R, et al. Repurposing brucine as a chemopreventive agent in mammary gland carcinoma: regulating lactate transport through MCT-4. Toxicol Rep. 2025;14:101902.","journal-title":"Toxicol Rep"},{"issue":"5","key":"444_CR39","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3324\/haematol.2018.199661","volume":"104","author":"I Spinello","year":"2019","unstructured":"Spinello I, Saulle E, Quaranta MT, et al. The small-molecule compound AC-73 targeting CD147 inhibits leukemic cell proliferation, induces autophagy and increases the chemotherapeutic sensitivity of acute myeloid leukemia cells. Haematologica. 2019;104(5):973\u201385.","journal-title":"Haematologica"},{"key":"444_CR40","first-page":"2422","volume":"110","author":"MEG Cantafio","year":"2025","unstructured":"Cantafio MEG, Valentino I, Torcasio R, et al. Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myeloma. Haematologica. 2025;110:2422\u201335.","journal-title":"Haematologica"},{"key":"444_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2025.101290","volume":"83","author":"Q Xiong","year":"2025","unstructured":"Xiong Q, Jin J, Lin J, et al. The role of synthetic lethality in overcoming cancer therapy resistance: emerging paradigm and recent advances. Drug Resist Updat. 2025;83:101290.","journal-title":"Drug Resist Updat"},{"key":"444_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2023.113330","volume":"226","author":"H Zhang","year":"2023","unstructured":"Zhang H, Liu R, Wan P, et al. Targeting tumor energy metabolism via simultaneous inhibition of mitochondrial respiration and glycolysis using biodegradable hydroxyapatite nanorods. Colloids Surf B Biointerfaces. 2023;226:113330.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"1","key":"444_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s40170-025-00379-1","volume":"13","author":"Y Chawla","year":"2025","unstructured":"Chawla Y, Anderson EI, Smith M, et al. Lactate metabolism in clonal plasma cells and its therapeutic implications in multiple myeloma patients with elevated serum LDH levels. Cancer Metab. 2025;13(1):9.","journal-title":"Cancer Metab"},{"issue":"1","key":"444_CR44","first-page":"1","volume":"15","author":"SV Medeiros","year":"2022","unstructured":"Medeiros SV. Investigating metformin & syrosingopine\u2019s synthetic lethality in PC3 & THP-1 cancer cell lines. Plymouth Stud Sci. 2022;15(1):1\u201322.","journal-title":"Plymouth Stud Sci"},{"key":"444_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1034397","volume":"12","author":"D Benjamin","year":"2022","unstructured":"Benjamin D, Hall MN. Combining metformin with lactate transport inhibitors as a treatment modality for cancer-recommendation proposal. Front Oncol. 2022;12:1034397.","journal-title":"Front Oncol"},{"key":"444_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241814124","author":"P Rainone","year":"2023","unstructured":"Rainone P, Valtorta S, Villa C, et al. Evaluating [(18)F]FDG and [(18)F]FLT radiotracers as biomarkers of response for combined therapy outcome in triple-negative and estrogen-receptor-positive breast cancer models. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241814124.","journal-title":"Int J Mol Sci"},{"key":"444_CR47","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.neuroscience.2024.11.049","volume":"565","author":"Y Zheng","year":"2025","unstructured":"Zheng Y, Yu X, Li W, et al. HLA is a potent immunoinflammatory target in asymptomatic Alzheimer\u2019s disease. Neuroscience. 2025;565:386\u201398.","journal-title":"Neuroscience"},{"key":"444_CR48","doi-asserted-by":"publisher","DOI":"10.1172\/JCI176207","author":"R Tiwari","year":"2024","unstructured":"Tiwari R, Sharma R, Rajendran G, et al. Postischemic inactivation of HIF prolyl hydroxylases in endothelium promotes maladaptive kidney repair by inducing glycolysis. J Clin Invest. 2024. https:\/\/doi.org\/10.1172\/JCI176207.","journal-title":"J Clin Invest"},{"issue":"5","key":"444_CR49","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1158\/2643-3230.BCD-22-0139","volume":"4","author":"K Toyoda","year":"2023","unstructured":"Toyoda K, Yasunaga JI, Shichijo T, et al. HTLV-1 bZIP factor-induced reprogramming of lactate metabolism and epigenetic status promote leukemic cell expansion. Blood Cancer Discov. 2023;4(5):374\u201393.","journal-title":"Blood Cancer Discov"},{"key":"444_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/biology10010060","author":"J V\u00e9lez","year":"2021","unstructured":"V\u00e9lez J, Velasquez Z, Silva LMR, et al. Metabolic signatures of Cryptosporidium parvum-infected HCT-8 cells and impact of selected metabolic inhibitors on C. parvum infection under physioxia and hyperoxia. Biology. 2021. https:\/\/doi.org\/10.3390\/biology10010060.","journal-title":"Biology"},{"key":"444_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/v16010082","author":"I Spinello","year":"2024","unstructured":"Spinello I, Saulle E, Quaranta MT, et al. AC-73 and syrosingopine inhibit SARS-CoV-2 entry into megakaryocytes by targeting CD147 and MCT4. Viruses. 2024. https:\/\/doi.org\/10.3390\/v16010082.","journal-title":"Viruses"},{"issue":"4","key":"444_CR52","doi-asserted-by":"publisher","first-page":"L439","DOI":"10.1152\/ajplung.00083.2024","volume":"327","author":"MN Tuineau","year":"2024","unstructured":"Tuineau MN, Herbert LM, Garcia SM, Resta TC, Jernigan NL. Enhanced glycolysis causes extracellular acidification and activates acid-sensing ion channel 1a in hypoxic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2024;327(4):L439\u201351.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"444_CR53","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1476-5381.1963.tb01501.x","volume":"21","author":"RM Quinton","year":"1963","unstructured":"Quinton RM. The increase in the toxicity of yohimbine induced by imipramine and other drugs in mice. Br J Pharmacol Chemother. 1963;21(1):51\u201366.","journal-title":"Br J Pharmacol Chemother"},{"issue":"1","key":"444_CR54","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1476-5381.1981.tb09966.x","volume":"74","author":"I Cavero","year":"1981","unstructured":"Cavero I, Lef\u00e8vre-Borg F, Roach AG. Effects of mianserin, desipramine and maprotiline on blood pressure responses evoked by acetylcholine, histamine and 5-hydroxytryptamine in rats. Br J Pharmacol. 1981;74(1):143\u20138.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"444_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02410-x","volume":"24","author":"P Kesharwani","year":"2025","unstructured":"Kesharwani P, Kumar V, Goh KW, et al. PEGylated PLGA nanoparticles: unlocking advanced strategies for cancer therapy. Mol Cancer. 2025;24(1):205.","journal-title":"Mol Cancer"},{"key":"444_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16020248","author":"S Yan","year":"2024","unstructured":"Yan S, Na J, Liu X, Wu P. Different targeting ligands-mediated drug delivery systems for tumor therapy. Pharmaceutics. 2024. https:\/\/doi.org\/10.3390\/pharmaceutics16020248.","journal-title":"Pharmaceutics"},{"key":"444_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.115083","volume":"202","author":"AS Mikhail","year":"2023","unstructured":"Mikhail AS, Morhard R, Mauda-Havakuk M, Kassin M, Arrichiello A, Wood BJ. Hydrogel drug delivery systems for minimally invasive local immunotherapy of cancer. Adv Drug Deliv Rev. 2023;202:115083.","journal-title":"Adv Drug Deliv Rev"},{"key":"444_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.855019","volume":"12","author":"S Chu","year":"2022","unstructured":"Chu S, Shi X, Tian Y, Gao F. pH-responsive polymer nanomaterials for tumor therapy. Front Oncol. 2022;12:855019.","journal-title":"Front Oncol"},{"issue":"5","key":"444_CR59","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1158\/1541-7786.MCR-22-0451","volume":"21","author":"JM Buschhaus","year":"2023","unstructured":"Buschhaus JM, Rajendran S, Chen S, et al. Bone marrow mesenchymal stem cells induce metabolic plasticity in estrogen receptor-positive breast cancer. Mol Cancer Res. 2023;21(5):458\u201371.","journal-title":"Mol Cancer Res"},{"issue":"12","key":"444_CR60","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1038\/s41591-024-03233-x","volume":"30","author":"K Huang","year":"2024","unstructured":"Huang K, Chandak P, Wang Q, et al. A foundation model for clinician-centered drug repurposing. Nat Med. 2024;30(12):3601\u201313.","journal-title":"Nat Med"},{"issue":"5","key":"444_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/app15052798","volume":"15","author":"S Herr\u00e1iz-Gil","year":"2025","unstructured":"Herr\u00e1iz-Gil S, Nygren-Jim\u00e9nez E, Acosta-Alonso DN, Le\u00f3n C, Guerrero-Aspizua S. Artificial intelligence-based methods for drug repurposing and development in cancer. Appl Sci. 2025;15(5):2798.","journal-title":"Appl Sci"},{"key":"444_CR62","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/cancers17010116","volume":"17","author":"L Liu","year":"2025","unstructured":"Liu L, Li F, Liu X, Wang K, Zhao Z. Novel computational and artificial intelligence models in cancer research. Cancers. 2025;17:116.","journal-title":"Cancers"},{"key":"444_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.108057","volume":"222","author":"LS Menig-Benzig","year":"2025","unstructured":"Menig-Benzig LS, St\u00fchler V, Mazzola P, et al. Drug targeting of the monocarboxylate transporter MCT4 is a novel treatment strategy for metastatic ccRCC. Pharmacol Res. 2025;222:108057.","journal-title":"Pharmacol Res"},{"issue":"1","key":"444_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02451-0","volume":"10","author":"X Shu","year":"2025","unstructured":"Shu X, Liu S, Yang T, et al. Alpha-enolase influences ATP pool of cytoplasm and lactate homeostasis by regulating glycolysis in gastric cancer. Signal Transduct Target Ther. 2025;10(1):356.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"444_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116854","volume":"45","author":"Y Li","year":"2026","unstructured":"Li Y, Wang C, Zhou S, Shi Y, Zhu D, Zheng X. Lactylation-driven nuclear RIG-I promoted by lactate transporter inhibitor suppresses DNA damage repair through inhibiting PARP1 activity. Cell Rep. 2026;45(1):116854.","journal-title":"Cell Rep"},{"issue":"1","key":"444_CR66","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202511348","volume":"38","author":"S Li","year":"2026","unstructured":"Li S, Tu Y, Tong S, et al. Molecularly engineered nanoagents with efficient free radicals generation and photothermal conversion performance for enhanced tumor photoimmunotherapy via targeting lactate metabolism-immune circuit rewiring. Adv Mater. 2026;38(1):e11348.","journal-title":"Adv Mater"},{"issue":"4","key":"444_CR67","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1007\/s12274-021-3948-0","volume":"15","author":"F Dong","year":"2022","unstructured":"Dong F, Jiang Q, Li L, et al. Synergetic lethal energy depletion initiated by cancer cell membrane camouflaged nano-inhibitor for cancer therapy. Nano Res. 2022;15(4):3422\u201333.","journal-title":"Nano Res"},{"issue":"10","key":"444_CR68","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1021\/acsmaterialslett.3c00616","volume":"5","author":"G Ravichandran","year":"2023","unstructured":"Ravichandran G, Harijan D, Ganapathy N, Prabusankar G, De A, Rengan AK. The multifaceted role of degradable cobalt nanoparticles: dual-target starvation and intracellular acidification engendering LC3-associated whole-cell autophagy. ACS Mater Lett. 2023;5(10):2726\u201338.","journal-title":"ACS Mater Lett"},{"key":"444_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2023.102057","volume":"54","author":"X Han","year":"2024","unstructured":"Han X, Xiang D, Li J, et al. ROS responsive nanoparticles mediated inhibition of monocarboxylic acid transporters to enhance chemoimmunotherapy by overcoming low immune response in osteosarcoma. Nano Today. 2024;54:102057.","journal-title":"Nano Today"}],"container-title":["Oncology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40487-026-00444-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40487-026-00444-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40487-026-00444-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T11:04:07Z","timestamp":1782385447000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40487-026-00444-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["444"],"URL":"https:\/\/doi.org\/10.1007\/s40487-026-00444-9","relation":{},"ISSN":["2366-1070","2366-1089"],"issn-type":[{"value":"2366-1070","type":"print"},{"value":"2366-1089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Moslem Javidan, Zahra Jafari, Shahdokht Abbasinia, Sirous Jamalzehi, Afsaneh Shafiei\u00a0and Ali Khodadadi have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}